Healthcare AI company Abridge has announced new deals with trillion-dollar companies Eli Lilly and Nvidia to develop its clinical conversation foundation model, as it aims to gain an edge in the competitive market supporting doctors and streamlining hospital billing and operations.[1042524][1015193] Abridge's AI scribe technology has gained momentum, especially thanks to its ability to help health systems bill for services more efficiently and comprehensively.[1015193] The company has disclosed nearly $800 million in funding and was most recently valued at over $5 billion.[1015193]